GB Sciences

About:

GB Sciences operates as a research and biotechnical development company.

Description:

GB Sciences (GBS) (OTC:GBLX) is a research and biotechnical development company setting the gold standard for manufacturing medical cannabis producing technology, as well as discovering, developing, and commercializing proprietary strains of cannabis to treat a broad range of serious medical conditions.

Total Funding Amount:

$2.02M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Las Vegas, Nevada, United States

Founded Date:

2001-04-04

Contact Email:

info(AT)gbsciences.com

Founders:

Jamillah Ali-Rahman

Number of Employees:

11-50

Last Funding Date:

2016-01-13

IPO Status:

Public

Industries: